Sleep Health Enhancement in Older Adults to Address Frailty

Sponsor
University of Kansas Medical Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05968820
Collaborator
(none)
40
2
12

Study Details

Study Description

Brief Summary

The objective of the proposed study is to tailor a sleep health enhancement intervention to older adults and assess preliminary efficacy on reducing frailty in older adults. This pilot study will be conducted in two stages. In the treatment development stage, we will recruit n=10 older individuals age ≥65 with poor sleep health (≤ 7 on the Ru-SATED self-report questionnaire) to assess acceptability and tailor the sleep health enhancement intervention for older adults. In the pilot study stage to assess preliminary efficacy of the tailored sleep health enhancement intervention, n=30 older adults with poor sleep health will be randomly assigned to a 4-week 1x/week, telehealth-delivered sleep health enhancement intervention or to a wait-list control condition. Participants will wear wrist-worn actigraphy, complete sleep, frailty, and quality of life questionnaires at baseline and reassessments.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Sleep Health Enhancement Intervention
Phase 1

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Tailoring a Sleep Health Enhancement Intervention for Older Adults to Address Frailty
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Sleep Health Enhancement Intervention

The sleep health enhancement intervention is a 4-week, 1x/week one-one-one program with a graduate research assistant who will be trained and supervised by the PI in provision of the sleep health enhancement intervention.

Behavioral: Sleep Health Enhancement Intervention
The program is based on principles from CBT-I (time in bed restriction, stimulus control, relaxation techniques, sleep education) and includes behavioral strategies to entrain circadian rhythm, strengthen sleep homeostasis, reduce hyperarousal, and sleep hygiene techniques. Self-Determination Theory (SDT) and Social Cognitive Theory (SCT) will serve as the theoretic framework for behavior change techniques (BCT) threaded through the sleep health enhancement intervention. Participants will maintain a sleep diary during the program to aid in tailoring the program, self-monitoring of behavior, and feedback of behavior. Goals will be set by the participant at each session and reviewed at subsequent sessions, and motivational interviewing principles will be incorporated.

No Intervention: Wait-List Control Group

The wait-list control group will be encouraged to continue with their usual activities and sleep habits during the wait period between baseline and reassessment and will undergo the sleep health enhancement intervention following the initial reassessment.

Outcome Measures

Primary Outcome Measures

  1. 6-item Acceptability Scale [6 week]

    5-point Likert scale on ease of use, understandability, enjoyment, perceived helpfulness, time commitment, and overall satisfaction

  2. semi-standardized qualitative interview [6 week]

    Feasibility and acceptability will be assessed via semi-structured interview with a trained graduate research assistant following standard qualitative methods to determine attitudes, perceptions and experiences of effectiveness, potential barriers, benefits, and likes/dislikes of the sleep health enhancement intervention. The interview will be recorded for analysis purposes

  3. Tilburg Frailty Indicator [baseline, 6 week and 12 week reassessments]

    The Tilburg Frailty Indicator consists of 15 questions with score ranging from 0-15 with a higher score indicating higher level of frailty. The physical, psychological, and social frailty sub scores range from 0-8, 0-4, and 0-3 respectively.

  4. WHOQOL-BREF [baseline, 6 week and 12 week reassessments]

    The WHOQOL-BREF consists of 26 items and 4 domains of quality of life (psychological, physical health, social relationships and environmental). Scores range from 4-20 for each domain and a higher score indicates higher quality of life.

  5. Ru_SATED sleep health composite [baseline, 6 week and 12 week reassessments]

    Ru-SATED sleep health composite will be calculated using actigraphy data and self-report questionnaires

Secondary Outcome Measures

  1. Pittsburgh Sleep Quality Index [baseline, 6 week and 12 week reassessments]

    Scores range from 0-21 with a higher score indicating a lower quality of sleep. A global score of >5 indicates poor sleep quality.

  2. Epworth Sleepiness Scale [baseline, 6 week and 12 week reassessments]

    Consists of eight scenarios of daily activity, and participants use a four-point Likert scale to rate how likely they are to doze.

  3. Dysfunctional Beliefs About Sleep [baseline, 6 week and 12 week reassessments]

    This assessment is a 10 item Likert-scale self-report questionnaire. Higher scores indicate more dysfunctional beliefs.

  4. Sleep Self-Efficacy [baseline, 6 week and 12 week reassessments]

    Sleep Self-Efficacy is a 9 item self-report Likert-scale questionnaire use to identify sleep self-efficacy. Scores range from 0-45 and a higher score indicates higher sleep self-efficacy.

  5. Actigraphy [baseline, 6 week and 12 week reassessments]

    Participants will wear an actigraph on their non-dominant wrist for 7 nights

Other Outcome Measures

  1. Timed Up and Go [baseline, 6 week and 12 week reassessments]

    Timed Up and Go measures functional mobility and consists of sitting in a chair, standing up, walking 3-m, turning around, returning to the chair, and sitting down. The outcome is the time in seconds it takes to complete the task.

  2. 15 ft walk test [baseline, 6 week and 12 week reassessments]

    The test is performed in a hallway or open space, and the time it takes to walk 15 ft is noted in seconds.

  3. 6-Minute Walk Test (6MWT) [baseline, 6 week and 12 week reassessments]

    The test is performed in a hallway or open space with two cones marking the turn-around points. The participant walks between the two cones for six minutes. Distance is measured by number of laps completed.

  4. Grip strength of the dominant and nondominant hand [baseline, 6 week and 12 week reassessments]

    Grip strength of the dominant and nondominant hand will be assessed using a dynamometer with the participant seated, elbow flexed to 90 degrees, and arm by their side. The participant will perform one practice submaximal effort for acclimation followed by one maximal effort squeeze.

  5. The Continuous Performance Test (CPT) [baseline, 6 week and 12 week reassessments]

    The Continuous Performance Test (CPT) requires participants to respond as quickly and accurately as possible to a series of stimuli that are delivered via computer. The participants will be instructed to tap the space bar for every letter except "X." The participants' scores will be determined by their scores in detectability (e.g., difficulty differentiating targets from non-targets), error type (e.g., omissions, commissions, perseverations) and reaction time statistics.

  6. The Stroop Test [baseline, 6 week and 12 week reassessments]

    The Stroop Test requires participants to inhibit the natural response (reading a word) and replace it with another response (saying a color). Each participant is given a list of X's printed in colored ink and a list of words printed in colored ink. The participant is instructed to name the color of the ink. They are given 45 seconds to name as many colors as they can. The reported outcome measure of this test is an interference score that is the difference between the two conditions while normalizing for number of x's using the following formulae: x-words/x.

  7. Cognitive Failures Questionnaire (CFQ) [baseline, 6 week and 12 week reassessments]

    Cognitive Failures Questionnaire (CFQ) assesses perception of cognitive abilities over the past 6 months. consists of 25 items that the individual rates on a 5-point Likert scale with 0 = "never" and 4 = "Very Often" with a summary score of 0-100 with a higher score indicating poorer perceived cognitive abilities.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. ≥65 years old, 2. ≤ 7 on the RU-SATED self-report questionnaire, and 3. MMSE ≥25 and AD8 <3.
Exclusion Criteria:
  1. Known untreated sleep disorder (such as sleep apnea or restless leg syndrome); 2. >3 on the STOP BANG indicating increased risk of sleep apnea; 3. Increased risk of restless legs syndrome on RLS-Diagnosis Index; 4. Evidence of circadian rhythm sleep-wake disorder; 5. Evidence of parasomnia; 6. Regular use (>2x/week) of prescription or over-the-counter medications to improve sleep; 7. Score of ≥15 on the Patient Health Questionnaire (PHQ-9) indicating severe depression or endorsement of any suicidal ideation (answer 1, 2 or 3 on #9 of the PHQ-9); 8. Score of ≥10 on the Generalized Anxiety Disorder (GAD-7) indicating moderate to severe anxiety; 9. Self-report of current or history (up to 2 years) of drug or alcohol abuse based on the DSM-5-TR criteria; 10. History of nervous system disorder such as stroke or Parkinson's disease; 11. Severe mental illness such as schizophrenia or bipolar disorder; 12. Current or history (within 5 years) of shift work including hours of midnight-4am; and 13. Is currently receiving a behavioral sleep health intervention.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Kansas Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Catherine Siengsukon, PT, PhD, Professor, University of Kansas Medical Center
ClinicalTrials.gov Identifier:
NCT05968820
Other Study ID Numbers:
  • STUDY00150428
First Posted:
Aug 1, 2023
Last Update Posted:
Aug 1, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Catherine Siengsukon, PT, PhD, Professor, University of Kansas Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 1, 2023